Literature DB >> 18806125

Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brain.

H Umesha Shetty1, Sami S Zoghbi, Fabrice G Siméon, Jeih-San Liow, Amira K Brown, Pavitra Kannan, Robert B Innis, Victor W Pike.   

Abstract

Metabotropic glutamate subtype-5 receptors (mGluR5) are implicated in several neuropsychiatric disorders. Positron emission tomography (PET) with a suitable radioligand may enable monitoring of regional brain mGluR5 density before and during treatments. We have developed a new radioligand, 3-fluoro-5-(2-(2-[(18)F](fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile ([(18)F]SP203), for imaging brain mGluR5 in monkey and human. In monkey, radioactivity was observed in bone, showing release of [(18)F]-fluoride ion from [(18)F]SP203. This defluorination was not inhibited by disulfiram, a potent inhibitor of CYP2E1. PET confirmed bone uptake of radioactivity and therefore defluorination of [(18)F]SP203 in rats. To understand the biochemical basis for defluorination, we administered [(18)F]SP203 plus SP203 in rats for ex vivo analysis of metabolites. Radio-high-performance liquid chromatography detected [(18)F]fluoride ion as a major radiometabolite in both brain extract and urine. Incubation of [(18)F]SP203 with brain homogenate also generated this radiometabolite, whereas no metabolism was detected in whole blood in vitro. Liquid chromatography-mass spectrometry analysis of the brain extract detected m/z 548 and 404 ions, assignable to the [M + H](+) of S-glutathione (SP203Glu) and N-acetyl-S-l-cysteine (SP203Nac) conjugates of SP203, respectively. In urine, only the [M + H](+) of SP203Nac was detected. Mass spectrometry/mass spectrometry and multi-stage mass spectrometry analyses of each metabolite yielded product ions consistent with its proposed structure, including the former fluoromethyl group as the site of conjugation. Metabolite structures were confirmed by similar analyses of SP203Glu and SP203Nac, prepared by glutathione S-transferase reaction and chemical synthesis, respectively. Thus, glutathionylation at the 2-fluoromethyl group is responsible for the radiodefluorination of [(18)F]SP203 in rat. This study provides the first demonstration of glutathione-promoted radiodefluorination of a PET radioligand.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806125      PMCID: PMC2679677          DOI: 10.1124/jpet.108.143347

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  36 in total

1.  Characterization of the fluoroacetate detoxication enzymes of rat liver cytosol.

Authors:  L Q Tu; Y-Y Chen; P F A Wright; C J Rix; R Bolton-Grob; J T Ahokas
Journal:  Xenobiotica       Date:  2005 Oct-Nov       Impact factor: 1.908

Review 2.  Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics.

Authors:  J N Commandeur; G J Stijntjes; N P Vermeulen
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

3.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.

Authors:  S Baez; J Segura-Aguilar; M Widersten; A S Johansson; B Mannervik
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes.

Authors:  Y Ma; L Lang; D O Kiesewetter; E Jagoda; M B Sassaman; M Der; W C Eckelman
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-05-05

Review 5.  The role of group I metabotropic glutamate receptors in schizophrenia.

Authors:  M Pietraszek; J Nagel; A Gravius; D Schäfer; W Danysz
Journal:  Amino Acids       Date:  2006-05-15       Impact factor: 3.520

Review 6.  Metabolism and functions of glutathione in brain.

Authors:  R Dringen
Journal:  Prog Neurobiol       Date:  2000-12       Impact factor: 11.685

7.  Mechanism for the oxidative defluorination of flunisolide.

Authors:  P J Teitelbaum; N I Chu; D Cho; L Tökés; J W Patterson; P J Wagner; M D Chaplin
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

Review 8.  Reactive intermediates and the dynamics of glutathione transferases.

Authors:  Rosanna Rinaldi; Erik Eliasson; Stellan Swedmark; Ralf Morgenstern
Journal:  Drug Metab Dispos       Date:  2002-10       Impact factor: 3.922

9.  Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET.

Authors:  Amira K Brown; Yasuyuki Kimura; Sami S Zoghbi; Fabrice G Siméon; Jeih-San Liow; William C Kreisl; Andrew Taku; Masahiro Fujita; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2008-12       Impact factor: 10.057

10.  Mechanistic studies on the bioactivation of diclofenac: identification of diclofenac-S-acyl-glutathione in vitro in incubations with rat and human hepatocytes.

Authors:  Mark P Grillo; Fengmei Hua; Charles G Knutson; Joseph A Ware; Chunze Li
Journal:  Chem Res Toxicol       Date:  2003-11       Impact factor: 3.739

View more
  18 in total

Review 1.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  The Dark Side of Fluorine.

Authors:  Yue Pan
Journal:  ACS Med Chem Lett       Date:  2019-06-20       Impact factor: 4.345

3.  Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles.

Authors:  Jerri M Rook; Mohammed N Tantawy; Mohammad S Ansari; Andrew S Felts; Shaun R Stauffer; Kyle A Emmitte; Robert M Kessler; Colleen M Niswender; J Scott Daniels; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn
Journal:  Neuropsychopharmacology       Date:  2014-09-22       Impact factor: 7.853

4.  Targeting the de novo biosynthesis of thymidylate for the development of a PET probe for pancreatic cancer imaging.

Authors:  Thushani D Nilaweera; Muhammad Saeed; Amnon Kohen
Journal:  Biochemistry       Date:  2015-01-27       Impact factor: 3.162

5.  Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.

Authors:  Fabrice G Siméon; Matthew T Wendahl; Victor W Pike
Journal:  J Med Chem       Date:  2011-01-05       Impact factor: 7.446

6.  Efficient and regioselective halogenations of 2-amino-1,3-thiazoles with copper salts.

Authors:  Fabrice G Siméon; Matthew T Wendahl; Victor W Pike
Journal:  J Org Chem       Date:  2009-03-20       Impact factor: 4.354

7.  Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111.

Authors:  S Eberl; A Katsifis; M A Peyronneau; L Wen; D Henderson; C Loc'h; I Greguric; J Verschuer; T Pham; P Lam; F Mattner; A Mohamed; M J Fulham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-04       Impact factor: 9.236

8.  Synthesis and characterization in monkey of [11C]SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors.

Authors:  Fabrice G Siméon; Jeih-San Liow; Yi Zhang; Jinsoo Hong; Robert L Gladding; Sami S Zoghbi; Robert B Innis; Victor W Pike
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-11       Impact factor: 9.236

Review 9.  PET radiotracers: crossing the blood-brain barrier and surviving metabolism.

Authors:  Victor W Pike
Journal:  Trends Pharmacol Sci       Date:  2009-07-16       Impact factor: 14.819

Review 10.  Metabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging.

Authors:  Rajapillai L I Pillai; Dnyanesh N Tipre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-07       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.